Covered recipient · General Payments record
MOHAMMAD A ABU-RUB
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology
General Payments · PY2018–2023
$1,407.58
- Reported across 46 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $208.66 | 9 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $54.95 | 2 |
| Genentech USA, Inc. | $47.98 | 2 |
| Horizon Pharma plc | $41.37 | 2 |
| Takeda Pharmaceuticals U.S.A., Inc. | $23.60 | 1 |
| Biogen, Inc. | $21.59 | 1 |
| TG THERAPEUTICS, INC. | $19.17 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (9)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AbbVie Inc. | $30.15 | 03/10/2023 | Food and Beverage | Undisputed | 01/23/2026 | 996084039 | CMS |
| AbbVie Inc. | $24.80 | 11/09/2023 | Food and Beverage | Undisputed | 01/23/2026 | 996084041 | CMS |
| Biogen, Inc. | $21.59 | 02/28/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1012236649 | CMS |
| Genentech USA, Inc. | $27.76 | 01/09/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1040476367 | CMS |
| Genentech USA, Inc. | $20.22 | 04/28/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1040476359 | CMS |
| Horizon Therapeutics plc | $22.76 | 03/10/2023 | Food and Beverage | Undisputed | 01/23/2026 | 986934269 | CMS |
| Horizon Therapeutics plc | $18.61 | 06/30/2023 | Food and Beverage | Undisputed | 01/23/2026 | 986934273 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $23.60 | 01/18/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1055324675 | CMS |
| TG Therapeutics, Inc. | $19.17 | 03/29/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1051477057 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2021, 2022, 2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.